NCT03819088View on ClinicalTrials.gov

Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

October 5, 2021

Study Completion Date

March 22, 2022

Conditions
Gastric CarcinomaLiver and Intrahepatic Bile Duct CarcinomaUnresectable Esophageal CarcinomaUnresectable Pancreatic Carcinoma
Interventions
DIETARY_SUPPLEMENT

Zinc

Given PO

Trial Locations (2)

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

Emory Saint Joseph's Hospital, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Emory University

OTHER

NCT03819088 - Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer | Biotech Hunter | Biotech Hunter